Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
0.5% cyclopentolate-tropicamide versus 1% cyclopentolate alternating with 1% tropicamide for pediatric refraction with dark irides
TCTR20250312005Phase 3Completed
- Sponsor
- Navamindradhiraj University
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclopentolate, tropicamide in ametropia, sponsored by Navamindradhiraj University. Started Jan 2024; status: completed.
02
Drugs
cyclopentolatetropicamide
03
Conditions
ametropia
Beyond the preview
Go deeper on TCTR20250312005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250312005.